US: Glenmark Pharmaceuticals, BluePoint Laboratories Recall 135 Batches of Blood Pressure Capsules Over Cardiac Arrest Fear
This recall, announced last week, is due to a dissolution failure that could lead to hyperkalemia, a condition characterized by high potassium levels, according to the US Food and Drug Administration (FDA).